By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – The US Food and Drug Administration has reopened its comment period for the public and stakeholders to respond to its oversight plans for laboratory-developed tests until September 15.

FDA reopened the comment period, which initially closed on August 15, because it had received requests from stakeholders who wanted more time to develop or provide their opinions and recommendations on the issue.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: human cytomegalovirus diversity, patterns of homologous recombination in E. coli, and more.

US lawmakers are considering eliminating the medical devices tax that is part of the Affordable Care Act.

Two research teams in China home in on a gene that gives rice a long, slender shape.

Marcia McNutt, the editor-in-chief of Science, has been nominated to become president of the US National Academy of Sciences.